Loading organizations...
Key people at Tichenor Ventures.
Tichenor Ventures operates as a venture capital firm solely focused on life sciences. It provides late-stage growth capital, primarily investing in Series D and E rounds for US-based biotechnology and healthcare companies. The firm targets innovative ventures poised for clinical and commercial milestones, advancing novel therapies and medical technologies.
Founded in 2009 by McHenry (Mac) Tichenor, the firm emerged from the insight that maturing life science companies need specialized capital and guidance. Tichenor, utilizing his private investment background, identified an opportunity to back ventures nearing critical development or market entry, bridging the funding gap for translating discoveries into health.
Tichenor Ventures' portfolio companies typically develop advanced biological and pharmaceutical products addressing unmet medical needs. The firm supports therapeutic innovators. Its vision is to facilitate pioneering medical technologies, contributing to improved global health outcomes and advancing patient care.
Key people at Tichenor Ventures.
Tichenor Ventures has 3 tracked investments across 2 companies. The latest tracked deal is $150.0M Series E in Peloton Therapeutics in February 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2019 | Peloton Therapeutics | $150.0M Series E | Derek Dirocco | 305 Ventures, Foresite Capital, The Column Group, Gregory Bailey, BVF Partners, Curative Ventures, Driehaus Capital Management, EcoR1 Capital, Eventide Asset Management, Nextech Invest, OrbiMed, Topspin Fund, Vida Ventures |
| Sep 1, 2016 | Peloton Therapeutics | $52.0M Series D | JIM Tananbaum | The Column Group, Nextech Invest, Remeditex Ventures, Topspin Fund |
| Jan 20, 2010 | Kolltan Pharmaceuticals | $10.0M Other Equity / Series B | Auven Therapeutics | — |
